These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 17545843

  • 1. Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
    Hesketh PJ, Lilenbaum RC, Chansky K, Dowlati A, Graham P, Chapman RA, Crowley JJ, Gandara DR.
    J Thorac Oncol; 2007 Jun; 2(6):494-8. PubMed ID: 17545843
    [Abstract] [Full Text] [Related]

  • 2. Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
    Hesketh PJ, Chansky K, Lau DH, Doroshow JH, Moinpour CM, Chapman RA, Goodwin JW, Gross HM, Crowley JJ, Gandara DR.
    J Thorac Oncol; 2006 Jul; 1(6):537-44. PubMed ID: 17409914
    [Abstract] [Full Text] [Related]

  • 3. Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
    Yoshimura N, Kudoh S, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Kodama T, Ichimaru Y, Yana T, Hirata K.
    J Thorac Oncol; 2009 Mar; 4(3):371-5. PubMed ID: 19155998
    [Abstract] [Full Text] [Related]

  • 4. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
    Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M.
    J Clin Oncol; 2006 Aug 01; 24(22):3657-63. PubMed ID: 16877734
    [Abstract] [Full Text] [Related]

  • 5. Elderly subgroup analysis of a randomized phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for first-line treatment of advanced nonsmall cell lung carcinoma (TAX 326).
    Belani CP, Fossella F.
    Cancer; 2005 Dec 15; 104(12):2766-74. PubMed ID: 16288485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Weekly vinorelbine and docetaxel as second-line chemotherapy for pretreated non-small cell lung cancer patients: a phase I-II trial.
    Nelli F, Naso G, De Pasquale Ceratti A, Saltarelli R, Dauria G, Lugini A, Ferraldeschi R, Picone V, Moscetti L, Cortesi E.
    J Chemother; 2004 Aug 15; 16(4):392-9. PubMed ID: 15332716
    [Abstract] [Full Text] [Related]

  • 8. Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
    Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY.
    Cancer Chemother Pharmacol; 2010 Oct 15; 66(5):889-97. PubMed ID: 20091311
    [Abstract] [Full Text] [Related]

  • 9. A phase II study of docetaxel and carboplatin in Thai patients with advanced non-small-cell lung cancer.
    Thongprasert S, Soorraritchingchai S, Chewaskulyong B, Charoentum C, Munprakan S.
    J Med Assoc Thai; 2006 Feb 15; 89(2):152-9. PubMed ID: 16579000
    [Abstract] [Full Text] [Related]

  • 10. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug 15; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 11. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA, Hoffman PC, Drinkard LC, Watson S, Samuels BL, Golomb HM, Vokes EE.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [Abstract] [Full Text] [Related]

  • 12. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ, Fournel P, Bohas CH, Fortune IC, Chatte G.
    Semin Oncol; 1996 Apr 15; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [Abstract] [Full Text] [Related]

  • 13. Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
    Descourt R, Vergnenegre A, Barlesi F, Lena H, Fournel P, Falchero L, Berard H, Hureaux J, Le Caer H, Chavaillon JM, Geriniere L, Monnet I, Chouabe S, Robinet G, GFPC VINCR Team.
    J Thorac Oncol; 2011 Feb 15; 6(2):351-7. PubMed ID: 21164367
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
    Davies AM, Chansky K, Lau DH, Leigh BR, Gaspar LE, Weiss GR, Wozniak AJ, Crowley JJ, Gandara DR, SWOG S9712.
    J Clin Oncol; 2006 Nov 20; 24(33):5242-6. PubMed ID: 17114656
    [Abstract] [Full Text] [Related]

  • 17. Dose-dense vinorelbine and docetaxel with Filgrastim support in patients with advanced nonsmall cell lung carcinoma.
    Page RD, Smith FP, Geils GF, Beall CL, Fridman M, Allen BJ.
    Cancer; 2005 Nov 01; 104(9):1956-61. PubMed ID: 16177986
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin in combination with metronomic vinorelbine as front-line treatment in advanced non-small cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Katsaounis P, Kotsakis A, Agelaki S, Kontopodis E, Agelidou A, Kentepozidis N, Vamvakas L, Christopoulou A, Karachaliou N, Hatzidaki D, Georgoulias V.
    Cancer Chemother Pharmacol; 2015 Apr 01; 75(4):821-7. PubMed ID: 25702051
    [Abstract] [Full Text] [Related]

  • 19. A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer.
    Lilenbaum R, Rubin M, Samuel J, Boros L, Chidiac T, Seigel L, Dowlati A, Graham P, Beaumont J, Du H.
    J Thorac Oncol; 2007 Apr 01; 2(4):306-11. PubMed ID: 17409802
    [Abstract] [Full Text] [Related]

  • 20. Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
    Califano R, Griffiths R, Lorigan P, Ashcroft L, Taylor P, Burt P, Lee L, Chittalia A, Harris M, Faivre-Finn C, Thatcher N, Blackhall F.
    Lung Cancer; 2011 Sep 01; 73(3):338-44. PubMed ID: 21296449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.